Cargando…
p53 mutations as a marker of malignancy in bladder washing samples from patients with bladder cancer
The diagnosis and follow-up of patients with bladder cancer rely on invasive procedures (cystoscopy with biopsy). Polymerase chain reaction (PCR)-based technologies may allow the sensitive detection of cancer-related genetic mutations in exfoliated tumour material, potentially allowing the developme...
Autores principales: | Phillips, H A, Howard, G C W, Miller, W R |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2000
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2363182/ https://www.ncbi.nlm.nih.gov/pubmed/10638980 http://dx.doi.org/10.1054/bjoc.1999.0890 |
Ejemplares similares
-
p53 mutations in urinary bladder cancer
por: Berggren, P, et al.
Publicado: (2001) -
Cigarette smoking and p53 mutations in lung cancer and bladder cancer.
por: Husgafvel-Pursiainen, K, et al.
Publicado: (1996) -
Somatic mutation of PTEN in bladder carcinoma
por: Aveyard, J S, et al.
Publicado: (1999) -
The utility of tumour markers in assessing the response to chemotherapy in advanced bladder cancer
por: Cook, A M, et al.
Publicado: (2000) -
Decreased expression of p57(KIP2)mRNA in human bladder cancer
por: Oya, M, et al.
Publicado: (2000)